About the benefits of immunotherapy for high-risk neuroblastoma

J Clin Oncol. 2013 Feb 10;31(5):649-50. doi: 10.1200/JCO.2012.47.4080. Epub 2013 Jan 7.

Authors

Lucas Moreno, Giuseppe Barone, Julie R Park, Andrew D J Pearson

PMID: 23295791
DOI: 10.1200/JCO.2012.47.4080

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage*
Humans
Immunoglobulin G / administration & dosage*
Isotretinoin / administration & dosage*
Male
Neuroblastoma / drug therapy*

Substances

Antibodies, Monoclonal
Immunoglobulin G
Granulocyte-Macrophage Colony-Stimulating Factor
Isotretinoin